COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,726 Articles (22,502 medRxiv, 8,224 bioRxiv)

Most recent first Previous |  Page 2130: Articles 21291-21300  | Next

Report on COVID-19 Verification Case Study in Nine Countries Using the SIQR model
reiji, s.
10.1101/2020.10.07.20208298 — Posted: 2020-10-09
Modelling testing and response strategies for COVID-19 outbreaks in remote Australian Aboriginal communities
Hui, B. B., Brown, D., Chisholm, R. H., Geard, N., McVernon, J., Regan, D. G.
10.1101/2020.10.07.20208819 — Posted: 2020-10-09
AncestryDNA COVID-19 Host Genetic Study Identifies Three Novel Loci
Roberts, G. H. L., Park, D. S., Coignet, M. V., McCurdy, S. R., Knight, S. C., Partha, R., Rhead, B., Zhang, M., Berkowitz, N., Science Team, A., Haug Baltzell, A. K., Guturu, H., Girshick, A. R., Rand, K. A., Hong, E. L., Ball, C. A.
10.1101/2020.10.06.20205864 — Posted: 2020-10-09
High seroprevalence of SARS-CoV-2 antibodies among people living in precarious situations in Ile de France
ROEDERER, T., MOLLO, B., VINCENT, C., NIKOLAY, B., LLOSA, A., NESBITT, R., VANHOMWEGEN, J., ROSE, T., ANNA, F., TORRE, C., FOURREY, E., GOYARD, S., JANIN, Y., CHARNEAU, P., VRATSKIKH, O., COURY, A., VANEL, S., MENDIHARAT, P., PORTEN, K., HENNEQUIN, W., MILLS, C., LUQUERO, F.
10.1101/2020.10.07.20207795 — Posted: 2020-10-09 Discussion: Onsite
Isolation of infected people and their contacts is likely to be effective against many short-term epidemics
Geffen, N., Low, M. O.
10.1101/2020.10.07.20207845 — Posted: 2020-10-09
Pulmonary Embolism in Patients with COVID-19: A Systematic review and Meta-analysis
Hamam, O., Goda, A., Awad, R., Ussama, A., Eldalal, M., Fayez, A., Baral, S., Elyamany, K., Bhandari, R., Egbe, A., Sharina, I.
10.1101/2020.10.09.20209965 — Posted: 2020-10-09
Reliability and limits of transport-ventilators to safely ventilate severe patients in special surge situations.
Savary, D., Lesimple, A., Beloncle, F., Morin, F., Templier, F., Broc, A., Brochard, L., Richard, J.-C., Mercat, A.
10.1101/2020.10.07.20208561 — Posted: 2020-10-09
Detecting and isolating false negatives ofSARS-CoV-2 primers and probe sets among the Japanese Population: A laboratory testing methodology and study
Tsutae, W., Chaochaisit, W., Aoshima, H., Ida, C., Miyakawa, S., Sekine, H., Afzal, S., Sato, I. B., Furukawa, T., Sekine, A.
10.1101/2020.10.07.20208264 — Posted: 2020-10-09
Psychiatric morbidity and protracted symptoms in recovered COVID-19 patients
Poyraz, B. C., Aksoy Poyraz, C., Olgun, Y., Gurel, O., Alkan, S., Ozdemir, Y. E., Balkan, I. I., Karaali, R.
10.1101/2020.10.07.20208249 — Posted: 2020-10-09
Diagnostic comparison of three fully automated chemiluminescent immunoassay platforms for the detection of SARS-CoV-2 antibodies
Parai, D., Dash, G. C., Choudhary, H. R., Peter, A., Rout, U. K., Nanda, R. R., Kshatri, J. S., Kanungo, S., Palo, S. K., Turuk, J., Pati, S., Bhattacharya, D. D.
10.1101/2020.10.07.20207696 — Posted: 2020-10-09

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).